Repligen (RGEN) had the highest return between March 30, 2014 and July 4, 2015 by a large-cap US stock, returning 219.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
Repligen (RGEN) | 3/30/2014 - 7/4/2015 | 219.55% |
Neurocrine Biosciences (NBIX) | 3/30/2014 - 7/4/2015 | 208.81% |
Skyworks Solutions (SWKS) | 3/30/2014 - 7/4/2015 | 183.73% |
Qorvo (QRVO) | 3/30/2014 - 7/4/2015 | 159.44% |
Palo Alto Networks (PANW) | 3/30/2014 - 7/4/2015 | 146.14% |
Centene (CNC) | 3/30/2014 - 7/4/2015 | 139.13% |
Broadcom (AVGO) | 3/30/2014 - 7/4/2015 | 117.08% |
NetEase (NTES) | 3/30/2014 - 7/4/2015 | 114.37% |
Ensign (ENSG) | 3/30/2014 - 7/4/2015 | 113.95% |
Interactive Brokers (IBKR) | 3/30/2014 - 7/4/2015 | 113.76% |
Incyte (INCY) | 3/30/2014 - 7/4/2015 | 109.73% |
Genmab A-S (GMAB) | 3/30/2014 - 7/4/2015 | 107.1% |
Biomarin Pharmaceutical (BMRN) | 3/30/2014 - 7/4/2015 | 105.28% |
Cigna (CI) | 3/30/2014 - 7/4/2015 | 101.23% |
DexCom (DXCM) | 3/30/2014 - 7/4/2015 | 96.68% |
United Therapeutics (UTHR) | 3/30/2014 - 7/4/2015 | 93.44% |
Edwards Lifesciences (EW) | 3/30/2014 - 7/4/2015 | 93.02% |
Vertex Pharmaceuticals (VRTX) | 3/30/2014 - 7/4/2015 | 92.55% |
Monster Beverage (MNST) | 3/30/2014 - 7/4/2015 | 91.02% |
Alnylam Pharmaceuticals (ALNY) | 3/30/2014 - 7/4/2015 | 90.83% |
Fortinet (FTNT) | 3/30/2014 - 7/4/2015 | 87.75% |
Coca-Cola Consolidated (COKE) | 3/30/2014 - 7/4/2015 | 82.19% |
Netflix (NFLX) | 3/30/2014 - 7/4/2015 | 82.1% |
MACOM Technology Solutions (MTSI) | 3/30/2014 - 7/4/2015 | 80.42% |
Universal Health Services (UHS) | 3/30/2014 - 7/4/2015 | 77.78% |
Large-cap stocks are treated as having a market cap of $10B+.